Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/calliditas-receives-notice-of-allowance-for-united-states-patent-application-covering-setanaxib-in-cancer-treatment-302110166.html
https://www.prnewswire.com/news-releases/calliditas-announces-an-additional-seven-year-orphan-drug-exclusivity-period-for-tarpeyo-302081089.html
https://www.prnewswire.com/news-releases/calliditas-year-end-report-january--december-2023-302066986.html
https://www.prnewswire.com/news-releases/invitation-to-the-presentation-of-calliditas-year-end-report-january--december-2023-302061418.html
https://www.prnewswire.com/news-releases/calliditas-provides-patent-update-302060858.html
https://www.fiercepharma.com/pharma/calliditas-wins-over-fda-full-approval-broader-label-tarpeyo
https://www.prnewswire.com/news-releases/calliditas-receives-notice-of-allowance-for-united-states-patent-application-covering-tarpeyo-302011470.html
https://www.prnewswire.com/news-releases/calliditas-announces-additions-to-the-management-team-302003070.html
https://www.prnewswire.com/news-releases/calliditas-presents-data-from-the-nefigard-phase-3-trial-at-the-17th-international-symposium-on-iga-nephropathy-iigann-tokyo-2023-301942923.html
https://www.prnewswire.com/news-releases/stada-and-calliditas-announce-the-filing-for-full-marketing-authorization-of-kinpeygo-in-the-eu-301941594.html